EMERGENCY:Wernicke encephalopathy is a medical emergency —call040-46324365immediately — 24 hours, 7 days— 24/7
Wernicke-Korsakoff syndrome (WKS) is a two-stage neurological condition caused by severe deficiency of thiamine (vitamin B1) — an essential cofactor for three key enzymes in cerebral glucose metabolism: pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase. Without thiamine, the brain cannot utilise glucose effectively: neurons in the metabolically most demanding regions — the mammillary bodies, thalamic nuclei, periaqueductal grey matter, and cerebellar vermis — become selectively oedematous, then haemorrhagic, then infarcted.
WKS is a two-stage neurological condition from severe thiamine (vitamin B1) deficiency. Thiamine is an essential cofactor for three enzymes critical for cerebral glucose metabolism: pyruvate dehydrogenase (PDH), alpha-ketoglutarate dehydrogenase (α-KDH), and transketolase. Without thiamine, these enzymes fail; the metabolically most demanding brain regions — mammillary bodies, medial thalami, periaqueductal grey matter, cerebellar vermis — become selectively oedematous, then haemorrhagic, then infarcted. Stage 1: Wernicke encephalopathy (WE) — the acute reversible syndrome: classic triad of ophthalmoplegia + ataxia + confusion (but the FULL TRIAD is present in only 16–20% of cases; the clinical rule is to treat on suspicion, not wait for all three features). Stage 2: Korsakoff syndrome (KS) — the chronic, often irreversible amnestic syndrome when WE is treated too late or inadequately. THE MOST IMPORTANT RULE: THIAMINE BEFORE GLUCOSE. IV glucose in a thiamine-depleted patient overwhelms residual PDH capacity, accumulates pyruvate and lactate, and directly precipitates or dramatically worsens WE. EFNS-recommended dose: 200 mg IV three times daily, continued until no further clinical improvement (not the inadequate "100 mg once" common in many Indian hospitals).
| Fact | Details |
|---|---|
| The rule | THIAMINE BEFORE GLUCOSE · In any malnourished/alcohol-dependent/bariatric/prolonged-vomiting patient · If glucose urgent: give thiamine SIMULTANEOUSLY, not after |
| Incomplete triad | Only 16–20% have all 3 features simultaneously · 80% of WE not diagnosed during life · Treat on suspicion + nutritional risk: do not wait for full triad |
| EFNS dose | 200 mg IV three times daily until no further clinical improvement (EFNS; not 100 mg once) · Infuse slowly over 30 minutes · Always before glucose · Then oral 100 mg TID for 1–3 months minimum · Add magnesium (required cofactor) |
| MRI sensitivity | ~53% in acute WE · Normal MRI does NOT exclude WE · Classic: T2/FLAIR mammillary bodies + periaqueductal grey + medial thalami · Korsakoff: mammillary body atrophy |
| Korsakoff | Anterograde amnesia · Confabulation (non-deceptive) · Preserved procedural memory · Irreversible in ~75–80% · Errorless learning for rehabilitation |
| India-specific | Post-bariatric WE: increasing with India bariatric surgery surge · 100 mg once: inadequate · Glucose without thiamine: a common iatrogenic trigger in Indian hospitals |
| CIWA-Ar | Assess concurrent alcohol withdrawal in alcohol-dependent patients · Treat both WE (thiamine) and withdrawal (benzodiazepines) simultaneously |
Thiamine (B1) cofactor for pyruvate dehydrogenase + α-ketoglutarate dehydrogenase + transketolase · All three are critical for cerebral energy metabolism.
Ophthalmoplegia (lateral rectus palsy, conjugate gaze palsy, nystagmus) · Ataxia (cerebellar) · Confusion (global confusional state) · ALL THREE present in only 16–20% of cases.
Alcohol dependence (chronic, most common) · Malnutrition (prolonged starvation, poverty) · Prolonged vomiting (hyperemesis gravidarum) · Post-bariatric surgery (gastric bypass, sleeve) · IV glucose without thiamine in hospital.
THIAMINE BEFORE GLUCOSE: in any malnourished or alcohol-dependent patient, always give thiamine IV before or with glucose · Glucose alone in a thiamine-depleted brain can precipitate acute Wernicke encephalopathy.
IV thiamine 200 mg three times daily (EFNS guideline), continued until no further clinical improvement · Then oral thiamine 100 mg three times daily · Give magnesium (required cofactor).
Dense anterograde amnesia (cannot form new memories) · Confabulation (fabricated but non-deceptive memory) · Relatively preserved procedural memory · Often irreversible.
Wernicke: T2/FLAIR hyperintensity in mammillary bodies + periaqueductal grey + medial thalami · Diffusion restriction in acute phase · Mammillary body atrophy in Korsakoff.
Underdiagnosed and under-treated · Triad complete in only 16–20%: unilateral eye sign + confusion = treat · Post-bariatric WE: increasing with bariatric surgery surge in India.
Wernicke-Korsakoff syndrome (WKS) is a two-stage neurological condition caused by severe deficiency of thiamine (vitamin B1) — an essential cofactor for three key enzymes in cerebral glucose metabolism: pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase. Without thiamine, the brain cannot utilise glucose effectively: neurons in the metabolically most demanding regions — the mammillary bodies, thalamic nuclei, periaqueductal grey matter, and cerebellar vermis — become selectively oedematous, then haemorrhagic, then infarcted.
The first stage is Wernicke encephalopathy (WE) — the acute, reversible syndrome. The second stage is Korsakoff syndrome (KS) — the chronic, often irreversible amnestic syndrome that develops when Wernicke encephalopathy is not treated promptly or fully. The transition from Wernicke to Korsakoff represents the shift from oedematous (treatable) to infarcted (permanent) mammillary bodies and thalamic nuclei. The window for treatment is the Wernicke phase: prompt, high-dose IV thiamine given before or during this phase can prevent Korsakoff syndrome. Delay means a lifetime of Korsakoff amnesia.
Emergency / Consultation
Speak directly with the KIMS Wernicke-Korsakoff team — all coordinated under one roof. Available 24 hours for acute presentations.
040-44885000Emergency line available 24 hoursThree foundational principles that explain why Wernicke encephalopathy is under-diagnosed and why missed cases progress to permanent Korsakoff amnesia at KIMS — the incomplete-triad problem that hides 80% of cases, the dangerous glucose-thiamine interaction that can be iatrogenically triggered in hospital, and the irreversible Korsakoff amnesia that follows infarction of the mammillo-thalamic memory circuit.
The classical triad of Wernicke encephalopathy (ophthalmoplegia + ataxia + confusion) is present simultaneously in only 16–20% of patients. Post-mortem studies consistently show that 80–80% of pathologically confirmed WE cases were not diagnosed clinically during life. This is because: (1) Many patients present with only one or two features. (2) Confusion and ataxia are attributed to intoxication or withdrawal in alcohol-dependent patients — without considering WE as the specific cause. (3) Eye movement abnormalities (particularly early lateral gaze restriction or subtle nystagmus) require a careful neuro-ophthalmological examination that is often not performed in an emergency context. The clinical rule: any patient with unexplained confusion in the context of nutritional risk (alcohol dependence, malnutrition, prolonged vomiting, bariatric surgery, IV feeding) should receive empirical IV thiamine immediately — waiting for the full triad to appear is waiting for permanent brain damage.
In patients with thiamine deficiency, cellular pyruvate dehydrogenase (PDH) is already functioning at minimal capacity. Administering intravenous glucose (e.g. 5% dextrose, 50% dextrose for hypoglycaemia) floods the brain with glucose that cannot be metabolised without thiamine — overwhelming residual PDH capacity, accumulating lactate and pyruvate, and directly precipitating or dramatically worsening Wernicke encephalopathy. This is the most important drug interaction in emergency neurology: ALWAYS GIVE THIAMINE BEFORE GLUCOSE in malnourished patients, alcohol-dependent patients, and anyone with nutritional risk. If glucose must be given urgently (severe hypoglycaemia), give thiamine IV simultaneously, not after.
When Wernicke encephalopathy is not treated (or treated too late, or with inadequate thiamine doses), the oedematous mammillary bodies and mediodorsal thalamic nuclei progress from reversible oedema to haemorrhage and infarction. The result is Korsakoff syndrome: the bilateral destruction of the mammillo-thalamic circuit essential for memory consolidation produces an anterograde amnesia of devastating severity. The person with Korsakoff syndrome cannot form any new memories. They live permanently in the present moment, unable to learn new information, unable to remember any event from the day before, unable to recognise their treating clinicians as anyone they have met. The memory gap typically extends retrograde for months to years before the onset of Korsakoff. Confabulation — producing fabricated but non-deceptive accounts to fill memory gaps — is characteristic and occurs without intent to deceive. Approximately 75–80% of patients who develop Korsakoff syndrome do not recover to independent function.
Wernicke-Korsakoff syndrome is diagnosed at KIMS through a structured emergency workflow that begins with clinical recognition and immediate empirical thiamine (never delayed by tests), uses MRI with T2/FLAIR and diffusion to identify the mammillary body, periaqueductal, and medial-thalamic signature, confirms and corrects the magnesium cofactor, and evaluates for coexisting alcohol withdrawal using the CIWA-Ar scale :
Thiamine blood levels are neither sensitive nor rapidly available. Wernicke encephalopathy is a clinical emergency diagnosis. The principle: if the diagnosis is suspected (confusion + nutritional risk, with or without eye signs or ataxia), treat immediately with IV thiamine. The benefit of treating an unnecessary case is negligible (thiamine toxicity is essentially zero). The cost of NOT treating a true case is Korsakoff syndrome. Serum thiamine confirms deficiency retrospectively but should not delay treatment.
Classic Wernicke MRI: symmetric T2/FLAIR hyperintensity in the mammillary bodies (best seen on coronal sequences), periaqueductal grey matter, medial thalami (pulvinar), and cerebellar vermis. Diffusion restriction in the acute phase. Mammillary body contrast enhancement. Sensitivity of standard MRI in acute WE is approximately 53% — a normal MRI does not exclude Wernicke encephalopathy. In Korsakoff syndrome: mammillary body atrophy is the chronic MRI finding.
Thiamine pyrophosphate requires magnesium as a cofactor for its enzymatic function. Hypomagnesaemia impairs the efficacy of thiamine treatment. Serum magnesium should be checked and corrected (IV magnesium sulphate if deficient) alongside thiamine administration.
In alcohol-dependent patients, Wernicke encephalopathy can coexist with or be masked by alcohol withdrawal syndrome. The CIWA-Ar (Clinical Institute Withdrawal Assessment for Alcohol) scale is used to assess withdrawal severity. Both WE and withdrawal must be treated simultaneously — benzodiazepines for withdrawal, high-dose IV thiamine for WE.
The KIMS Wernicke-Korsakoff programme is built around two integrated care areas — high-dose IV thiamine as the time-critical acute Wernicke treatment (the EFNS-recommended 200 mg IV three times daily, followed by long-term oral thiamine, with magnesium correction and absolute avoidance of pre-thiamine glucose), and the chronic Korsakoff long-term programme (abstinence, continued thiamine, structured care environment, errorless-learning neuropsychological rehabilitation, and long-term care placement where required).
High-Dose IV Thiamine — The Time-Critical Treatment: The overarching principle: the window for preventing Korsakoff amnesia is the acute Wernicke phase, and high-dose IV thiamine is the single intervention that closes it. The KIMS protocol uses the EFNS-recommended high-dose regimen, not the inadequate single 100 mg dose still common in many Indian hospitals.
Acute Wernicke: Thiamine 200 mg IV three times daily (infused slowly over 30 minutes), continued until there is no further clinical improvement. This is the EFNS-recommended regimen (Galvin et al., 2010) and is substantially higher than the "100 mg once" dose that is commonly (inadequately) given in India. Thiamine must be given before any glucose infusion in at-risk patients.
Then: Oral thiamine 100 mg three times daily for at least 1–3 months (or lifelong in patients who continue to drink).
Magnesium: IV magnesium sulphate 4–8 mmol if serum magnesium is low · Oral magnesium for ongoing supplementation.
Glucose: Never administer glucose-containing IV fluids to a malnourished patient before thiamine has been given.
Korsakoff Syndrome — Long-Term Management: Korsakoff syndrome has no specific pharmacological treatment that reverses the amnesia. Management is supportive: (1) Abstinence from alcohol — ongoing alcohol use accelerates further neurological damage. (2) Continued thiamine supplementation. (3) Structured care environment — consistent routines, environmental cues, clear labelling, familiar carers. (4) Neuropsychological rehabilitation — errorless learning techniques (which use the preserved procedural memory system to build new habits) can teach some practical skills despite the anterograde amnesia. (5) Long-term care placement in many cases.
Related Conditions
Wernicke-Korsakoff syndrome belongs to the family of acquired brain injuries evaluated and managed at KIMS Neuroscience. Explore related acquired-brain-injury conditions.
A malnourished patient who was given glucose before thiamine. A bariatric patient who cannot walk or move their eyes normally. An alcohol-dependent person whose memory has vanished. Wernicke-Korsakoff syndrome is preventable and its worst outcome — permanent Korsakoff amnesia — is avoidable with prompt, high-dose thiamine.
At KIMS Hyderabad, the neurology team provides emergency thiamine treatment, neuroimaging, and long-term Korsakoff rehabilitation. Call 040-44885000.
International enquiries: info@kimsneurosciences.com